Search results (8)
« Back to NewsThe latest news, stories and exciting findings from across the Oxford cancer research community
OCION: In conversation with Dave Withers
17 June 2024
Through the Oxford Cancer Immuno-Oncology Network (OCION), we aim to apply Oxford's leading expertise in fundamental immunology to enable more patients, with a wide range of cancer types, to benefit safely from tailored immunotherapy use. We sat down with Professor David Withers, who recently moved to Oxford, to discuss his research.
OCION Funding Scheme: In conversation with David Church and Luciana Gneo
10 May 2024
The mission of the Oxford Cancer Immuno-Oncology Network (OCION) Funding Scheme is to pump-prime innovative Oxford-based immuno-oncology research and build capacity in cancer immunology. We sat down with 2023 awardees, David Church and Luciana Gneo, to discuss what research the fund will enable them to carry out.
Nuffield Department of Medicine receives funding to improve bowel cancer treatment
23 November 2022
The Leedham Lab in the Nuffield Department of Medicine (NDM) has been awarded over £2M from Cancer Research UK to develop a new tool that could help guide how bowel cancer patients are treated in the future.
Assessing a combined approach for risk-stratified population screening for colorectal cancer
10 November 2022
Polygenic risk scores only modestly improve the predictive power of the QCancer-10 non-genetic risk score for colorectal cancer.
Blood tests provide no additional information to FIT alone when prioritising patients for colorectal cancer referral
15 March 2022
Faecal immunochemical testing (FIT) alone leads to the identification of the same number of patients with colorectal cancer as more complicated approaches that combine the FIT result with the results of commonly used blood tests.
Bowel cancer patients going undiagnosed due to COVID distruption
15 January 2021
A new study led by the University of Oxford has found that since the first coronavirus lockdown the number of people diagnosed with bowel cancer in England has fallen sharply, with a deficit persisting up to October 2020.
IL-22 pathway linked to poor prognosis in colon cancer
21 August 2020
Research shows how IL-22 interacts with KRAS mutant tumours to promote excessive growth in colorectal cancer
The relationship between unexpected weight loss & cancer
13 August 2020
New research will help GPs to identify the signs they should look for to swiftly diagnose cancer in people with unexpected weight loss